Sites Menu > Medication Information - Anticoagulants


Medication Information - Anticoagulants


THE LACK OF EFFECT OF WARFARIN ON PLATELETS

Warfarin Institute of America

My hair is falling out. Is warfarin (Coumadin) to blame?

January, 2006. Unfortunately, there is not much data on this issue, but some patients on warfarin (Coumadin) do report hair loss. In over approximately 20 years of managing anticoagulation in several hundred patients annually, I have seen a few patients who have noticed hair loss after starting on warfarin...

Colonoscopy or surgery while on coumadin® (Bridging Therapy)

Last Updated: 8/24/05

SAFETY OF OUTPATIENT DENTAL TREATMENT FOR PATIENTS ON COUMADIN (WARFARIN) THERAPY

Warfarin Insitute of America

Initiation and Management of Coumadin Therapy


How warfarin works

How warfarin affects clotting factors

Anticoagulant Therapy Monitoring Guidelines


WHY DO SOME PEOPLE TAKE BOTH WARFARIN (Coumadin, Jantoven) AND ASPIRIN?

Warfarin Institute of America - Last update January 23, 2007

Coumadin resistance

Last Updated: 2/15/2004

Understanding Teenagers and Children Taking Coumadin®


Drug Interactions with Coumadin

Although access to this page is not restricted, the information found here is intended for use by medical providers. Patients should address specific medical concerns with their physicians. © 2000, Family Practice Notebook, LLC . These pages are best viewed with Microsoft Internet Explorer 5.0 or greater for full functionality.

What are anticoagulants?


Anticoagulation Therapy

Hematology 2001 © 2001 The American Society of Hematology. Despite refinements and standardization in the use of anticoagulants, many problems remain for clinicians. Dr. Crowther describes appropriate starting and maintenance doses of warfarin, factors accounting for inter- and intra-observer variability and importantly, the management of the over-anticoagulated patients and bleeding patients. Dr. White compares unfractionated heparin (UFH) and low molecular weight heparin (LMWH) and addresses whether there truly are differences in the efficacy and safety of different LMWH's for both arterial and venous indications. Dr. Ortel discusses the management of the problem patient who requires anticoagulants, the management of heparin-induced thrombocytopenia, the pregnant patient, the obese patient, patients who have renal insufficiency and/or liver disease, patients with malignant disease, and other challenging patient populations.

UCSF STUDY FINDS POPULAR BLOOD THINNER DOES NOT WEAKEN BONES

Warfarin, a popular blood thinner used to treat conditions such as heart and leg clots and irregular heart beats, does not weaken the bones of older women, a new UC San Francisco study has found. 18 June 1998

Long-term, low-intensity warfarin prevents recurrent VT

Results of the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial illustrate how pharmacist-managed anticoagulation dosing can help patients and clinicians walk a very important 'tightrope.'

Warfarin Therapy in Children

May 2004

Coumadin (warfarin) and Your Diet

The main dietary concern of taking warfarin (common brand name: Coumadin) has to do with the amount of vitamin K in your diet. Vitamin K changes the way warfarin affects the blood. When you eat foods that are high in vitamin K, you can decrease the effect of warfarin. Likewise, eating less vitamin K can increase the effect of the medication.

THE MOST OUTRAGEOUS PIECES OF ADVICE GIVEN TO WARFARIN PATIENTS

Warfarin Institute of America

Warfarin-Induced Skin Necrosis (WISN)

Last updated July 17, 2005

Breastfeeding and Coumadin®

Last Updated: 2/15/2004

Warfarin-Induced Skin Necrosis (WISN)


Can I take Tylenol with Coumadin® (warfarin)?

Overall, there have been very few reports of acetaminophen-associated effects on warfarin therapy. For decades, acetaminophen, the medicine in Tylenol, has been recognized as the over-the-counter pain reliever of choice for patients on warfarin therapy because Tylenol — unlike aspirin, naproxen sodium, ketoprofen, and even ibuprofen — does not cause gastrointestinal bleeding, nor does it inhibit the aggregation of platelets critical to normal blood clotting. It is very important that patients on warfarin have their blood clotting function monitored by their doctor and not change over-the-counter pain relievers without first consulting their doctors. If you are under a doctor's care for any serious condition or are taking any other drug, you should talk to your doctor if you want to know more or have other questions.

Dental Extraction and Rat Poison

Sunday 22 January 2006

Factors That Influence INR system Comparisons

List includes Antiphospholipid Antibodies. The APSFA does not promote, sell or make money from this company nor the vendors that sell them. However, if this document has been relocated again, please feel free to contact us for it.

Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation



[1] [2] [3] [4] Next



 

 

The APS Foundation of America, Inc. website and forums are both volunteer run and funded by donations to the APSFA.

Website hosted by Dreamhost. Website created and maintained by Heidi P.

DISCLAIMER: APS Foundation of America, Inc. website is not intended to replace standard doctor-patient visits, physical examination, and medical testing. Information given to members is only an opinion. All information should be confirmed with your personal doctor. Always seek the advice of a trained physician in person before seeking any new treatment regarding your medical diagnosis or condition. Any information received from APS Foundation of America, Inc. website is not intended to diagnose, treat, or cure. This site is for informational purposes only. Please note that we will be listing all donor or purchaser's names on the Donor page of our foundation site. If you do not want your name listed, please contact us to opt out. If you think you may have a medical emergency, call your doctor or 911 immediately.

APS Foundation of America, Inc. will be building a database with your email, name and address information for future mailings. Your information will be kept confidential and not sold to any third parties. You may opt out at anytime by emailing us.

APSFA ©2005-2016 | APSFA Privacy Policy | APSFA Advertising Policy | 501(c)3 Public Charity EIN #203085295